Report cover image

Ophthalmology & Retinal Disease: Gene Therapy Leadership & Mechanism Expansion

Publisher ResearchCubes
Published Mar 31, 2026
Length 70 Pages
SKU # RCUB21142060

Description

FDA Fast Track for AAV-based complement modulation in geographic atrophy. Retinal gene therapy as CGT beachhead. Durability of effect critical. Broader retinal disease application potential. Manufacturing scale-up for high-volume procedures.

Table of Contents

70 Pages
EXECUTIVE SUMMARY
1.1 Ophthalmology Market Opportunity
1.2 Retinal Gene Therapy Landscape
2.0 MECHANISM ADVANCEMENT
2.1 AAV Vector Optimization
2.2 Complement Modulation
2.3 Novel Targets
3.0 CLINICAL DEVELOPMENT
3.1 Durability Assessment
3.2 Long-Term Follow-Up
3.3 Patient Selection
4.0 MANUFACTURING STRATEGY
4.1 Manufacturing Scale-Up
4.2 Distributed Manufacturing
4.3 Supply Chain
5.0 MARKET EXPANSION
5.1 Indication Expansion
5.2 Geographic Reach
5.3 Pricing Strategy
"
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.